| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01d74e1f4b646c6f83d40ae812413f8f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-0115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b06ce979303b0931970ab9fb4870155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c803c56e11247c60b0e5602d6c3cb71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_420a5cb33c672ec162d557422f5952c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f62aeaed0b28abe8f22913aa58aa539e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77405e19543dc3da3a48424b1b73ad14 |
| publicationDate |
2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103417967-A |
| titleOfInvention |
Application of inhibitor of CXCL-10 in preparation of drug for treatment and/or prevention of lung injury |
| abstract |
The invention relates to application of the inhibitor of CXCL-10 in preparation of a drug for treatment and/or prevention of lung injury, and particularly relates to the application of the inhibitor of CXCL-10 in preparation of the drug for treatment and/or prevention of the lung injury of mammals including human. The lung injury of the mammals including human is induced by influenza viral infection, bacterial infection and/or fungal infection, and septicemia. The inhibitor of CXCL-10 can reduce or knock out the expression of the CXCL-10 in mammals. The inhibitor of CXCL-10 is selected from antibodies specific for the CXCL-10, siRNA, or any other chemical or biological substance reducing and/or knocking out the expression of the CXCL-10. The application of the inhibitor of CXCL-10 in preparation of the drug for treatment and/or prevention of the lung injury provides a new-action-mechanism drug for the treatment of the lung injury. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018227440-A1 |
| priorityDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |